Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1016/j.bjane.2017.03.003
Brazilian Journal of Anesthesiology
Scientific Article

Low dose propofol vs. lidocaine for relief of resistant post-extubation laryngospasm in the obstetric patient

Dose baixa de propofol versus lidocaína para alívio de laringoespasmo resistente pós-extubação em paciente obstétrica

Ali M. Mokhtar; Ahmed A. Badawy

http://dx.doi.org/10.1016/j.bjane.2017.03.003 Braz J Anesthesiol, vol.68, n1, p.57-61, 2018
PDF English
PDF Português
Downloads: 0
Views: 961

Abstract

Abstract Background Post-extubation laryngospasm is a dangerous complication that should be managed promptly. Standard measures were described for its management. We aimed to compare the efficacy of propofol (0.5 mg.kg-1) vs. lidocaine (1.5 mg.kg-1) for treatment of resistant post-extubation laryngospasm in the obstetric patients, after failure of the standard measures. Method This study was conducted over 2 years on all obstetric patients scheduled for cesarean delivery. Post-extubation laryngospasm was initially managed with a standard protocol (removal of offending stimulus, jaw thrust, positive pressure ventilation with 100% oxygen). When this protocol failed, the tested drug was the second line (lidocaine in the first year and propofol in the second year). Lastly, succinylcholine was used when the tested drug failed. Results In lidocaine group, 5% of parturients developed post-extubation laryngospasm, 31.9% of them were successfully treated via standard protocol, and 68.1% required lidocaine treatment. Among these, 65.6% of patients treated with lidocaine responded successfully and 34.4% required succinylcholine to relieve laryngospasm. In propofol group, 4.7% of parturients developed post-extubation laryngospasm, 30.1% of them were successfully treated via standard protocol, and 69.9% required propofol treatment. Among these, 82.8% of patients treated with propofol responded successfully and 17.2% required succinylcholine to relieve laryngospasm. Conclusion Small dose of propofol (0.5 mg.kg-1) is marginally more effective than lidocaine (1.5 mg.kg-1) for the treatment of resistant post-extubation laryngospasm in obstetric patients, after failure of standard measures and before the use of muscle relaxants.

Keywords

Propofol, Lidocaine, Laryngospasm, Obstetric

Resumo

Resumo Justificativa O laringoespasmo pós-extubação é uma complicação perigosa que deve ser prontamente tratada. Medidas padrão para o seu manejo foram descritas. O nosso objetivo foi comparar a eficácia de propofol (0,5 mg.kg-1) versus lidocaína (1,5 mg.kg-1) no tratamento de laringoespasmo resistente pós-extubação em pacientes obstétricas após falha das medidas padrão. Método Este estudo foi conduzido ao longo de dois anos em todas as pacientes obstétricas programadas para cesariana. O laringoespasmo pós-extubação foi inicialmente tratado com um protocolo padrão (remoção do estímulo ofensivo, protrusão mandibular, ventilação com pressão positiva com oxigênio a 100%). Ao constatar a falha desse protocolo, o fármaco testado foi a segunda opção (lidocaína no primeiro ano e propofol no segundo ano). Por fim, succinilcolina foi usada quando houve falha do fármaco testado. Resultados No grupo lidocaína, 5% das parturientes desenvolveram laringoespasmo pós-extubação, 31,9% delas foram tratadas com sucesso via protocolo padrão e 68,1% precisaram de tratamento com lidocaína, das quais, 65,6% responderam com sucesso ao tratamento com lidocaína e 34,4% precisaram de succinilcolina para alívio do laringoespasmo. No grupo propofol, 4,7% das parturientes desenvolveram laringoespasmo pós-extubação, 30,1% delas foram tratadas com sucesso via protocolo padrão e 69,9% precisaram de tratamento com propofol, das quais, 82,8% responderam com sucesso ao tratamento com propofol e 17,2% precisaram de succinilcolina para alívio do laringoespasmo. Conclusão Uma pequena dose de propofol (0,5 mg.kg-1) é marginalmente mais eficaz do que lidocaína (1,5 mg.kg-1) no tratamento de laringoespasmo resistente pós-extubação em pacientes obstétricas, após falha das medidas padrão e antes do uso de relaxantes musculares.

Palavras-chave

Propofol, Lidocaína, Laringoespasmo, Obstetrícia

References

Rose DK, Cohen MM, Wigglesworth DF. Critical respiratory events in the postanesthesia care unit: patient, surgical, and anesthetic factors. Anesthesiology. 1994;81:410-8.

Rex MA. A review of the structural and functional basis of laryngospasm and a discussion of the nerve pathways involved in the reflex and its clinical significance in man and animals. Br J Anaesth. 1970;42:891-9.

Nishino T. Physiological and pathophysiological implications of upper airway reflexes in humans. Jpn J Physiol. 2000;50:3-14.

Lemyze M, Mallat J. Understanding negative pressure pulmonary edema. Intensive Care Med. 2014;40:1140-3.

Ghofaily LA, Simmons C, Chen L. Negative pressure pulmonary edema after laryngospasm a revisit with a case report. J Anesth Clin Res. 2013;3:252.

Phillips OC. The role of anesthesia in obstetric mortality. Int Anesthesiol Clin. 1968;6:847-73.

Phillips OC, Davis GH, Frazier TM. The role of anesthesia in obstetric mortality a review of 455,553 live births from 1936 to 1958 in the city of Baltimore. Anesth Analg. 1961;40:557-66.

Fodale V, Pratico C, Leto G. Propofol relieves post-extubation laryngospasm in obstetric anesthesia. Int J Obstet Anesth. 2004;13:196-7.

Pilkington S, Carli F, Dakin MJ. Increase in Mallampati score during pregnancy. Br J Anaesth. 1995;74:638-42.

Stehling LC. Management of the airway. Clin Anesth, 7th ed. 2013:p784-5.

Larson PC. Laryngospasm - the best treatment. J Am Soc Anesthesiol. 1998;89:1293-4.

Hobaika AB, De S, Lorentz MN. Laryngospasm review article. Rev Bras Anestesiol. 2009;59:487-95.

Warner DO. Intramuscular succinylcholine and laryngospasm. Anesthesiology. 2001;95:1039-40.

Zeidan A, Halabi D. Aerosolized lidocaine for relief of extubation laryngospasm (letter). Anesth Analg. 2005;101:1562-3.

Baraka A. Intravenous lidocaine controls extubation laryngospasm in children. Anesth Analg. 1978;57:506-7.

Sibai AN, Yamout I. Nitroglycerin relieves laryngospasm. Acta Anaesthesiol Scand. 1999;43:1081-3.

Afshan G, Chohan U, Qamar-Ul-Hoda M. Is there a role of a small dose of propofol in the treatment of laryngeal spasm?. Pediatr Anesth. 2002;12:625-8.

McKeating K, Bali IM, Dundee JW. The effects of thiopentone and propofol on upper airway integrity. Anaesthesia. 1988;43:638-40.

Pak HJ, Lee WH, Ji SM. Effect of a small dose of propofol or ketamine to prevent coughing and laryngospasm in children awakening from general anesthesia. Korean J Anesthesiol. 2011;60:25-9.

Leicht P, Wisborg T, Chraemmer-Jørgensen B. Does intravenous lidocaine prevent laryngospasm after extubation in children?. Anesth Analg. 1985;64:1193-6.

Batra YK, Ivanova M, Ali SS. The efficacy of a subhypnotic dose of propofol in preventing laryngospasm following tonsillectomy and adenoidectomy in children. Paediatr Anaesth. 2005;15:1094-7.

Al-Metwalli RR, Mowafi HA, Ismail SA. Gentle chest compression relieves extubation laryngospasm in children. J Anesth. 2010;24:854-7.

5dcc5d070e8825ea21bf58f1 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections